| FORM 8.3 - Amendment to section 2a |
| | | | | | |
| Replaces form released 17:43 on 13 February 2024 |
| | | | | | |
| RNS number: 0334D |
| | | | | | |
| | | | | | | | |
| FORM 8.3 | |||||||
| PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY | |||||||
| A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR | |||||||
| MORE | |||||||
| Rule 8.3 of the Takeover Code (the "Code") | |||||||
| 1. | KEY INFORMATION | ||||||
| (a) | Full name of discloser: | Barclays PLC. | |||||
| (b) | Owner or controller of interest and short |
| |||||
| (c) | Name of offeror/offeree in relation to whose | KIN & CARTA PLC | |||||
| (d) | If an exempt fund manager connected with an |
| |||||
| (e) | Date position held/dealing undertaken: | 12 Feb 2024 | |||||
| (f) | In addition to the company in 1(c) above, is the discloser making | n/a | |||||
| 2. | POSITIONS OF THE PERSON MAKING THE DISCLOSURE | ||||||
| (a) | Interests and short positions in the relevant securities of the offeror or offeree | ||||||
| Class of relevant security: | 10p ordinary | ||||||
| | Interests | Short Positions | |||||
| Number | (%) | Number | (%) | ||||
| (1) Relevant securities owned and/or controlled: | 9,785,628 | 5.49% | 93,777 | 0.05% | |||
| (2) Cash-settled derivatives: | 80,643 | 0.04% | 9,785,628 | 5.49% | |||
| (3) Stock-settled derivatives (including options) and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||
| | 9,866,271 | 5.54% | 9,879,405 | 5.55% | |||
| (b) | Rights to subscribe for new securities (including directors and | ||||||
| Class of relevant security in relation to | | ||||||
| Details, including nature of the rights | | ||||||
| 3. | DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE | ||||||
| (a) | Purchase and sales | ||||||
| Class of relevant | Purchase/sale | Number of | Price per unit | ||||
| 10p ordinary | Purchase | 59,043 | 1.2749 GBP | ||||
| 10p ordinary | Purchase | 42,781 | 1.2757 GBP | ||||
| 10p ordinary | Purchase | 16,549 | 1.2740 GBP | ||||
| 10p ordinary | Purchase | 4,331 | 1.2727 GBP | ||||
| 10p ordinary | Purchase | 4,106 | 1.2720 GBP | ||||
| 10p ordinary | Purchase | 88 | 1.2718 GBP | ||||
| 10p ordinary | Sale | 26,969 | 1.2752 GBP | ||||
| 10p ordinary | Sale | 16,694 | 1.2740 GBP | ||||
| 10p ordinary | Sale | 15,042 | 1.2766 GBP | ||||
| 10p ordinary | Sale | 4,340 | 1.2727 GBP | ||||
| 10p ordinary | Sale | 1,373 | 1.2760 GBP | ||||
| 10p ordinary | Sale | 1,257 | 1.2780 GBP | ||||
| 10p ordinary | Sale | 88 | 1.2720 GBP | ||||
| (b) | Cash-settled derivative transactions | ||||||
| Class of | Product description | Nature of dealing | Number of | Price per | |||
| 10p ordinary | CFD | Increasing Short | 3,566 | 1.2739 GBP | |||
| 10p ordinary | CFD | Increasing Short | 4,106 | 1.2720 GBP | |||
| 10p ordinary | CFD | Increasing Short | 55,477 | 1.2751 GBP | |||
| 10p ordinary | SWAP | Decreasing Short | 2,014 | 1.2769 GBP | |||
| | | | | | | | |
| (c) | Stock-settled derivative transactions | ||||||
| (i) | Writing, selling, purchasing or varying | ||||||
| Class | Product | Writing, | Number | Exercise | Type | Expiry | Option |
| | | | | | | | |
| | | | | | | | |
| (ii) | Exercising |
| | | | | |
| Class of relevant | Product description | Exercising/ exercised against | Number of | Exercise price per | |||
| | | | | | |||
| | | | | | | | |
| (d) | Other dealings (including subscribing for | ||||||
| Class of relevant | Nature of Dealings | Details | Price per unit (if | ||||
| | | | | ||||
| 4. | OTHER INFORMATION | ||||||
| (a) | Indemnity and other dealings arrangements | ||||||
| Details of any indemnity or option arrangement, or any agreement or understanding, | |||||||
| NONE | |||||||
| (b) | Agreements, arrangements or understandings relating to options or | ||||||
| Details of any agreement, arrangement or understanding, formal or informal, between | |||||||
| NONE | |||||||
| (c) | Attachments |
| | | | | |
| Is a Supplemental Form 8 (Open Positions) attached? | NO | ||||||
| Date of disclosure: | 27-Feb-24 | ||||||
| Contact name: | Large Holdings Regulatory Operations | ||||||
| Telephone number: | 020 3134 7213 | ||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
